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INTRODUCTION 
Dyspepsia is not a diagnosis but it refers to a group of symptoms related to the 
pathology of upper gastrointestinal tract
1
. According to American 
gastroenterological association dyspepsia refers to chronic and recurrent pain or 
discomfort centred in the upper abdomen.Rome IIIcriteria for dyspepsia must 
include one or more of the following 
                    - postprandial fullness 
                    - early satiation  
                    - epigastric pain  
                    - epigastric burning 
A clear diagnosis based on these symptoms will be difficult. Many diseases cause 
dyspepsia namely gastric and duodenal ulcers,oesophagitis,gastric and pancreatic 
cancer, gall stones etc. But in majority of  patients with dyspepsia no clear 
pathologic cause can be determined and it is known as functional dyspepsia. 
Upper gastro intestinal endoscopy is the most sensitive test for patients presenting 
with dyspepsia. But when taken into account, inthe large population of dyspeptic 
patients endoscopy cannot be done practically for all of them. It is even more 
difficult in developing countries like India where diagnostic facilities are limited. 
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There is no standard age cut off for patients above which endoscopy is indicated. 
So this topic was undertaken in Kilpauk medical college in Chennai to study the 
role of endoscopy in management of patients with dyspepsia symptom complex. 
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AIM OF STUDY 
1.To study the various endoscopic findings in dyspeptic patients and to study the 
usefulness of endoscopy in patients presenting with dyspepsia with or without 
alarm symptoms 
2. Incidence of H pylori in patients with dyspepsia  
3. Incidence of oesophageal and gastric cancer in patients presenting with 
dyspepsia 
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REVIEW OF LITERATURE 
Dyspepsia is derived from two Greek words: dys-poor and pepsin-digestion. There 
is no standard definition for dyspepsia. Dyspepsia symptom complex include a 
number of vague symptoms like upper abdominal pain, epigastric burning,early 
satiety or fullness,heart burn, nausea and regurgitation. The alarm symptoms when 
serious pathology should be considered include  
               -any persistent dyspepsia in patients above 55 years of age 
                        -weight loss 
                        -gastro intestinal bleeding 
                        -persistent vomiting 
                        -dysphagia 
                        -epigastric mass 
                        -previous gastric ulcer 
                        - iron deficiency anemia 
                        -gastric surgery 
                        -suspicious barium meal 
                        -anti inflammatory drugs usage 
12 
 
                        -hospitalisation for epigastric pain 
Dyspeptic patients can be broadly divided into two subtypes-organic or 
pathological and functional. Most of the patients fall into the second 
subtype.ROME III criteria for functional dyspepsia  include the above said 
symptoms-early satiety,epigastric pain or discomfort and postprandial fullness with 
no evidence of structural disease. In western countries nearly 15% of population is 
affected by functional dyspepsia
2
. Though only 1 in 4 persons with dyspeptic 
symptoms consult the doctor, it possesses a considerable clinical burden due to 
high incidence,more so in developing countries
3
. 
 Dyspepsia patients can be divided after endoscopy into  
   -ulcer like 
   -dysmotility like 
   -reflux like  
 - nonspecific groups 
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CAUSES OF DYSPEPSIA 
 
LUMINAL GI TRACT 
 
• Peptic ulcer disease 
• Gastroesophageal disease 
• Gastric or oesophageal neoplasia 
• Gastroparesis(eg. DM, post-vagotomy, scleroderma, chronic intestinal 
pseudo obstruction, post-viral,idiopathic) 
 Infiltrative and inflammatory gastric disorders (eg.Crohn's 
disease,eosinophilic gastroenteritis,sarcoidosis,amylodosis) 
• Gastric infections (cytomegalovirus,fungus,TB,syphilis) 
• Parasites (Giardia lamblia, Strongyloides stercoralis) 
• Chronic gastric volvulus 
• Chronic gasrtric or intestinal ischemia 
• Food intolerance 
• Irritable bowel syndrome 
• Functional dyspepsia 
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MEDICATIONS 
 
• Ethanol 
• Gemfibrozil 
• Estrogens 
• Glucocorticoids 
• Colchicine 
• Iron 
• Aspirin (other NSAIDs including COX-2 selective agents 
• Digitalis preparations 
• Levodopa 
• Narcotic 
• Niacin 
• Nitrates 
• Orlistatin 
• Potassium chloride 
• Quinidine 
• Sildenafil 
• Theophylline 
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Pancreatico biliary disorders 
 
• Biliary pain  (cholelithiasis ,choledocholithiasis, sphincter 
of Oddi dysfunction) 
• Chronic pancreatitis 
• Pancreatic neoplasms 
 
Systemic disorders 
 
• Myocardial ischemia 
• Congestive cardiac failure 
• Diabetes mellitus 
• Thyroid disease 
• Hyperparathyroidism 
• Intra abdominal malignancy 
• Pregnancy 
• Renal insufficiency 
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EPIDEMIOLOGY 
   The prevalence of dyspepsia according to the various world wide population 
study is around 25% ( range 10-40%) for a 3-12 month period
4
. But if heart burn or 
regurgitation are excluded, prevalence rate will be only around 3-15 %
5
. In less 
than 50% of the patients symptoms resolve over time according to the longitudinal 
studies
6
. 
    The prevalence of dyspepsia is higher in women than men. This difference 
decreases as the age increases. New onset dyspepsia will be seen in approximately 
5% of population each year
7
. 
   In Mumbai, study was conducted which reported that 33.3% of the population 
had dyspeptic symptoms and significant symptoms was present in nearly 12% of 
the population
8
 
Prevalence
9
 based on the symptoms include 
-reflux symptoms 25% 
-dyspepsia without reflux symptoms 15% 
-irritable bowel smptoms 15% 
-GERD 10% 
17 
 
According to the study conducted by Breslin NP et al ‗Study on gastric cancer and 
other endoscopic diagnosis in patients with  dyspepsia without alarm symptoms‘ 
among  2867 patients under 45 years only 3 cases of gastric cancer was 
dignosed
10
.So they concluded that doctor should consider endoscopy only for 
persistent or recurrent symptoms and not for all dyspeptic patients. Study 
conducted by Vakil N in 2741 patients also yielded the same result
11
. 
Lieberman D et al conducted study in endoscopic results in 99558 patients among 
which dyspeptic patients are 43% and among dyspeptic patients 36.5% are less 
than50 yrs without alarm symptoms
12
. They found that gastric cancer was related 
to increasing age,male sex,North American and Asian race. 
According to the study conducted by Choomsri P et al in 291 patients only 19% 
had significant endoscopic findings
13
. More importantly, alarm symptoms was not 
related to endoscopic findings.30 among the 130 patients who were biopsied were 
positive for H pylori
14
. Similarly, H pylori infection was not associated with 
significant endoscopic findings. They concluded that dyspeptic symptoms were not 
associated significantly with endoscopic findings and hence empirical anti-acid 
therapy should be given first before subjecting the patient to diagnostic endoscopy. 
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In 50 patients with dyspepsia, endoscopic findings were studied by Khan N et al. 
In this study there were 35 males and 15 females and 41 patients were in the age 
group of 30-50 years. Epigastric discomfort was present in 90% of the cases 
followed by heart burn in 72% of cases. In half of these cases(50%) there was no 
significant endoscopic findings. Esophagitis (12%) was the most common 
endoscopic finding followed by gastric ulcer and duodenal ulcer in 10% and 8% 
respectively
15
. Carcinoma stomach was diagnosed in 1 case (2%). They also 
concluded that dyspeptic symptoms was not significantly associated with 
endoscopic findings. 
Goh K L et al studied the association between H pylori and gastrointestinal 
disease. They also compared rapid urease test with culture, gram staining and 
histology. They concluded that rapid urease test, with 99.3%positive predictive 
value and 96.2% negative predictive value, is a reliable and rapid test for diagnosis 
of H pylori infection
16
. 
A study was conducted by Saba Fakhrieh about evaluation of endoscopic findings 
in Iranian patients with dyspepsia. Study was conducted over a period of 14 
months in 940 out patients with dyspepsia. On comparing ulcer dyspepsia with non 
ulcer dyspepsia, ulcer like dyspepsia was common presenting in 69.3% of the 
patients under study. Peptic ulcer was the most common finding in ulcer like 
dyspepsia patients presenting in 133 cases (14.1%). Risk factor such as alcohol and 
19 
 
smoking was associated with peptic ulcer patients significantly.H pylori was 
present in 68.4% of peptic ulcer patients and 41.5% of patients with non ulcer 
dyspepsia
17
. 
   Thomson  A B R et al did endoscopy for 1040 patients with dyspepsia.603 cases 
among 1040 cases showed significant endoscopic findings. Oesophagitis was 
present in 43% of the cases which was the most common finding and peptic ulcer 
in 5.3% cases was the least common finding. Alarm symptoms was present in only 
2.8% of the cases. Most of the patients had multiple dyspeptic symptoms. Nearly 
45% of cases had ulcer like symptoms followed by reflux like symptoms (38%) 
and dysmotility like dyspepsia(18%)
18
. But endoscopic findings did not correlate 
well with endoscopic findings. In patients with reflux like symptoms,oesophagitis 
was the most common finding.H  pylori infection was present in 301 cases and 
endoscopic findings were positive in many of these cases. It was concluded that the 
dyspeptic symptoms have little value in predicting endoscopic findings. This study 
similar to previous studies conclude that patient should be treated with acid 
suppressive therapy and endoscopy should be considered only in persisting 
symptoms in case of uncomplicated dyspepsia. 
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A study was conducted by Nowshad Khan et al to find the common causes of 
dyspepsia in Peshawar, Pakistan. Study was conducted for 6 months in 50 patients. 
Most of them were male in age grup of 30 - 50 years. Epigastric pain with 
discomfort was the most common symptom presenting in 90% of the patients.no 
significant endoscopic findings were noted in 25% of the population
19
. Among the 
endoscopy positive cases oesophagitis was the most common finding seen in 12% 
of the cases followed by gastric ulcer in 10% of the patients. Carcinoma stomach 
was present in 2% of the cases. 
Among  254 patients studied by Singh V et al patients, who attended the out 
patient department 147 patients were subjected to endoscopic biopsy for 
histopathology. Among the 147 cases, 80 were symptomatic and 67 did not have 
any symptoms. Among symptomatic patients 61.3% were positive for H pylori and 
56.7% of asymptomatic were positive for H pylori infection
20
.H pylori was 
positive in 11 out of 13 cases of peptic ulcer. 
A study was conducted by Yasmeen Khan et al to evaluate endoscopy findings in 
patients with symptoms of dyspepsia. It was conducted in Chhattisgarh, India. It 
was a retrospective study conducted on 593 patients for a period of 6 months. All 
patients with dyspepsia who underwent endoscopy were included in the 
study.64.9% of the patients were male and females were 35.1%. Mean age was 42 
years. In this study, gastritis was the most common endoscopic finding and gastric 
21 
 
ulcer patients(6.7%)  were more common than duodenal ulcer patients(4%)
21
. 
Gastric carcinoma was present in 4.6% of patients and oesophageal carcinoma was 
present in 3.7% of patients. Normal endoscopic findings were seen in 40% of 
patients. 
   Study conducted by Dalaney et al about the cost effectiveness of endoscopy 
compared to first treat and then test policy in patients over 50 years of age suggest 
that initial endoscopy is cost effective than usual management
22
 
Sumathi et al did a study on ‗Appropriateness of indication for endoscopy in 
India‘. Among 3432 south Indian patients with dyspepsia for whom endoscopies 
were done 18.3%(284 patients) were diagnosed with malignancy and they were 
between the age group of 25-45 years. They concluded that the cut off age for 
malignancy in male as 38 years and 43.5 years for males. 
Uehara et al –a total of 32,388 dyspeptic patients were included and 285 gastric 
cancer cases were detected among which 45 cases were without alarm symptoms. 
They concluded that cut off age for gastric cancer in dyspeptic patients without 
alarm symptoms should be above 40 yrs of age
23
. 
According to study conducted by Casburn-Jones AC et al among 135 patients 
diagnosed to have gastric cancer in age group above 55 years only 8 cases were 
without alarm symptoms and among them only 1 patient was in the curable stage
24
. 
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So according to this study, even in patients above 55 years endoscopy does not 
significantly reduce the mortality rate. 
Gillen et al following his study on role of endoscopy in dyspeptic patients found 
that gastric and oesophageal malignancies are extremely rare in dyspeptic patients 
below 55 years and also if malignancy is diagnosed they are usually in incurable 
stage
25
. Hence there is no indication for endoscopy for all dyspeptic patients below 
55 years without alarm symptoms. 
Marmo et al found that age limit for endoscopy should be decreased for males and 
increased in females to reduce the rate of missing gastric cancers. They concluded 
that age along with gender should be considered for deciding on the age limit for 
endoscopy . 
Williams et al concluded that young patients with dyspepsia without alarm 
symptoms should not be over investigated and should be treated with acid 
suppressive therapy. 
Christie et al in their study found that only <  1% of cases were diagnosed with 
gastric cancer in age less than 55 years and hence age limit for endoscopy in 
dyspeptic patients without alarm symptoms can be 55 years
26
. 
According to the study conducted by Phull PS in Scottish patients gastric 
malignancy were uncommon in age less than 55 years and if they rarely occur, they 
23 
 
present with alarm symptoms. So raising thecut off age  from 45 to 55 years for 
endoscopy for dyspeptic patients does not significantly affect the outcome
27
. 
Mimica M et al did a study to find out the cut off age for gastric cancer in 
developing countries (Herzegovnia-Bosnia). A prospective study was done for 4 
years and found that if cut off age for endoscopy is 50 years for male and 60 years 
for female then the work load can be reduced to 50% without significantly 
affecting the outcome
28
. 
A Study was conducted byLiou JM et al in Taiwan where the incidence of gastric 
cancer was high. It was concluded that if cut off age was fixed at 45 years nearly 
5% of the gastric cancers were missed. So the cut off age of 40 years for both 
genders would be optimal in places were incidence of gastric cancer was high. 
According to the studyconducted by Wai CT in Asian patients in Singapore, 
among 5,066 patients 14.6% had peptic ulcer,5% had oesophagitis,0.47% had 
gastric cancer and 0.06% had oesophageal cancer.Gastric cancer was noted in 1.15 
of 1000 in patients less than 45 years and 9.60 of 1000 in patients above 45 years 
of age.They concluded that 45years as cut off age for endoscopy in simple 
dyspepsia in Singapore and it varies depending on the local incidence of gastric 
cancer
29
. 
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EPIGASTRIC PAIN SYNDROME 
 
 
Must  include  ALL   the  following
• Pain or burning localized to the epigastrium of atleast moderate severity,at least once 
per week
• Pain is intermittent
• Not generalized or localized to other abdominal or chest regions
• Not relieved by defecation or passage of flatus
• Not fulfilling  criteria for gallbladder or spincter of Oddi disorders
Supportive  criteria
• Pain may be of a burning quality,but without a retrosternal component 
• Pain is commonly induced or relieved by ingestion of a meal,but may occur while 
fasting
• Postprandial distress syndrome may coexist
26 
 
POSTPRANDIAL PAIN SYNDROME 
 
 
 
 
 
 
Must include one or both of  the 
following
• Bothersome postprandial fullness,occuring after 
ordinary-sized meals,atleast several times per week
• Early satiation that prevents finishing a regular 
meal,atleast several times per week
Supportive criteria
• Upper abdominal bloating or 
postprandial nausea or excessive 
belching can be present
• Epigastric pain syndrome may 
coexist
27 
 
                                       FUNCTIONAL DYSPEPSIA 
 
 
 
 
 
 
 
 
 
 
ANATOMY 
OESOPHAGUS 
Oesophagus allows passage of food into the stomach and is 25-30 cm in length. Its 
origin is at the cricoid cartilage at the level of fifth cervical vertebra to oesophago 
gastric junction at the level of twelfth thoracic vertebra. It is located in front of 
spine and behind the trachea. It enters the thorax at the sternal notch and it passes 
28 
 
in the posterior mediastinum in the thoracic cavity. Oesophageal hiatus is opposite 
tenth thoracic vertebra. 
Based on the anatomy,oesophagus is divided into  
           -cervical 
           -thoracic 
           -abdominal 
Functionally it is divided into 
           -upper and lower oesophageal sphincter 
           -body of oesophagus 
The pharyngo oesophageal junction is the narrowest part of alimentary canal. The 
superior,middle constrictor just above upper oesophageal sphincter help in 
deglutition and speech. Oesophagus has four constrictions 
     -at pharyngo oesophageal junction 
     -crossing of aortic arch 
     -crossing of left bronchus 
.  -when it pierces the diaphragm 
The normal constriction should be kept in mind during endoscopy 
29 
 
 
UPPER OESOPHAGEAL SPHINCTER 
The zone of high pressure at pharngo oesophageal junction is the upper 
oesophageal sphincter. Complex muscles of larynx and neck end at this level. The 
three pharyngeal constrictor muscles end at the crest of oesophagus. 
The pharyngeal constrictor muscle along with posterior cricoarytenoid muscle 
anchor pharynx to structures of mouth. These muscles are responsible for 
swallowing and speech but they are not the reason for high pressure in upper 
oesophageal sphincter.  
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LOWER OESOPHAGEAL SPHINCTER 
It is located at the oesophageal gastric junction allowing the food to enter the 
stomach.Lower oesophgeal sphincter is not a true sphincter. Atleast 2 cm length is 
required for normal functioning of sphincter. It has a high pressure zone of around 
2-5 cm length with resting pressure of about 6 to 25 mm Hg. This transition can be 
measured using a manometric tracer called Respirator inversion point. Here the 
pressure changes to positive from negative during inspiration and vice versa during 
expiration. 
   Along with peristaltic contraction, relaxation of the lower oesophageal sphincter 
by vagal stimulation is required to open the sphincter. Vagal relaxation of sphincter 
lasts for 4 to 6 seconds and occurs 1.5 to 2.5 seconds after pharyngeal swallowing. 
This timed relaxation is required for food to enter the stomach from oesophagus. 
After the food had entered the stomach, lower oesophageal sphincter contracts and 
the pressure returns to the baseline and acts as a reflux barrier.  
OESOPHAGEAL LAYERS 
   The two proper layers of oesophagus include mucosa and muscularis propria. 
Oesophagus does not contain serosal layer differentiating it from other gastro 
intestinal tract structures. The mucosa is made of squamous epithelium and is the 
innermost layer. The lowermost 1-2 cm is the transition zone where oesophageal 
31 
 
squamous epithelium and columnar epithelium of stomach meet at a point called as 
Z line.  
The layers of oesophagus include 
      -epithelium 
      -basement membrane 
      -lamina propria 
      -submucosa 
      -muscularis mucosa 
 
Histology 
   Outer to muscularis mucosa is submucosa and immediately outer to submucosa 
is muscularia propria. Oesophagus contains two layers of muscle bundle namely 
outer longitudinal and inner circular muscles. Upper one third of oesophagus has 
striated muscles and lower two third has smooth muscles. 
The inner circular muscle is the extension of cricopharyngeus muscle and on 
reaching the stomach they continue as the circular muscles of stomach along the 
lesser curvature. This transition occurs at the collar of Helvetius at the level of 
cardiac notch. This layer of oesophagus contain the Auerbach‘s plexus of nerve 
32 
 
fibres. Surrounding these circular muscle layer is the longitudinal muscle layer. 
Similar to the circular muscle layer it extends into the stomach and alimentary 
tract. 
 
 
. 
STOMACH 
The stomach is the most dilatable and the widest part of alimentary tract.it is 25 cm 
in length. Stomach is divided into  
              -cardiac part 
33 
 
              -pyloric part 
Cardiac part is further subdivided into  
              -fundus 
              -body 
Pylorus is subdivided into 
              -antrum 
              -canal 
The part of the stomach which is situated above the cardiac end of stomach is the 
fundus of stomach. Body of stomach extends from fundus to incisura angularis  
along the lesser curvature. Pylorus is situated below the body of stomach which is 
divided into antrum and canal. 
 
34 
 
 
 
Layers of stomach are 
 -mucosa 
              -submucosa 
              -muscle coat 
              -serosal coat 
35 
 
When the stomach is empty mucosa has rugae. These rugae are irregular except in 
lesser curvature where they are longitudinal. Rugae disappears in distended 
stomach.  The single layer of lining epithelium is known as ‗surface mucosal cells‘ 
as they secrete mucus. The mucus protects the stomach from action of enzymes 
and acids. Liquids usually reach the lesser curvature so it is the most common site 
of peptic ulcer. Mucosal layer contains many depression called gastric pits. 
Damage to the mucus layer directly exposes the stomach wall to the acids and 
enzymes and forms the basis for ‗leaking roof‘ hypothesis of peptic ulcer. 
Muscle layer has outer longitudinal and inner circular fibres. Circular fibres form 
the pyloric sphincter. Deepest layers namely oblique fibres form the gastric canal.
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Gastric Glands 
It can be subdivided into  
      -Cardiac glands 
      - Main gastric glands 
      - Pyloric glands 
Cardiac glands 
       They are tubular glands located near the oesophageal opening and has 
secreting cells. 
Main gastric glands 
       They are located in the fundus and body of stomach. They contain various 
cells namely peptic cells,oxyntic cells,neck cells and endocrine cells. Peptic cells 
secrete pepsin and located in the basal portion. 
Oxyntic cells secrete hydrochloric acid and also intrinsic factor. Both oxyntic cells 
and mucous cells are located in the upper part. Endocrine cells namely D-cells and 
enterochromaffin like cells are present all over the gland secreting somatostatin 
and histamine respectively. Gastrin secreting cells are called as G-cells are located 
in the lower part of gastric glands. There are also many cells without any 
differentiation and their functions are not known. 
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Pyloric glands 
They are located in the pylorus and secrete parietal,endocrine and mucous cells. 
 
 
 
PHYSIOLOGY 
Around 2.5 litres of gastric juice is produced daily. Hydrochloric acid produced by 
the juice produce a medium for pepsin to act. The mucus content protects the 
gastric mucosa from acid by forming a gel like layer and also secretes bicarbonate 
so that though pH is less in the luminal side,pH becomes basic on the surface 
epithelial cells thus preventing the epithelial damage. Helicobacter pylori are 
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concentrated in the mucus layer and damage to the mucus layer leads to the 
pathogenesis of H.pylori. 
Gastric secretion and motility are controlled by 
a- neural mechanism by autonomic cholinergic neurons 
b- hormonal mechanism by gastro intestinal hormones 
 
The three phases of gastric secretions are 
   -cephalic phase 
   -gastric phase 
   -intestinal phase 
Cephalic phase 
By direct cholinergic stimulation through activation of vagal centre. Oxyntic cells 
and parietal cells are stimulated leading to digestive enzymes  and acid secretion. 
Gastric phase 
Distension of stomach by food activates the vagal reflex which leads to the 
secretion of gastrin by the G-cells. 
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Intestinal phase 
Similar to gastric phase, once the food enters the intestine ,neuronal receptors get 
activated leading to intestinal gastrin secretion. Once pH in the duodenum and 
antrum decreases, further secretion of acid is inhibited due to vagal inhibition. 
 
 
STRUCTURAL CAUSES OF DYSPEPSIA 
HIATUS HERNIA 
It is herniation of part of the stomach through a defect or opening in the 
diaphragm. It occurs in 10% of the people but usually does not cause any 
symptoms
32
. 
Hiatus hernia leads to  weakening of the lower oesoghageal sphincter leading to 
reflux which causes heart burn. But all cases of hiatus hernia do not cause heart 
burn. 
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GASTROESOPHAGEAL REFLUX DISEASE 
It occurs when the pressure in the lower oesophagus is low and hence does not 
prevent regurgitation of gastric contents or when the lower oesophageal sphincter 
undergoes spontaneous relaxation. Heart burn is the usual symptom. As said above 
hiatus hernia is one of the causes for regurgitation. Long standing heart burn is the 
usual symptom. It usually occurs in the epigastric area and doesnot radiate to the 
back. 
 
 
BARRETT’S OESOPHAGUS 
Long standing exposure to acid ultimately changes squamous epithelium to 
columnar epithelium [metaplasia] with goblet cells. It is a premalignant condition 
for development of adenocarcinoma. It is estimated that the risk of 
adenocarcinoma is 6-7 per 1000 patients
32
. Patients usually have heart 
burn,dysphagia,hematemesis and pain in retrosternal area. Barrett‘s oesophagus is 
not associated with severity of heart burn but associated with duration of heart 
burn. 
Endoscopic biopsy helps in the diagnosis. But many patients donot have 
metaplasia. It is recommended that if two successive endoscopic biopsy is negative 
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then patient need not undergo endoscopy for 3 years. Low grade dysplasia can be 
managed conservatively but regular screening by endoscopic biopsy should be 
done. In case of high grade dysplasia,oesophagectomy, endoscopic mucosal 
resection or ablation can be done. 
 
 
PEPTIC ULCER DISEASE 
It is discontinuity of the mucosal lining of stomach or the first part of duodenum. It 
is due to the effect of pepsin and acid when the mucosal barrier get deranged. 
Acute ulcers may be shallow but chronic ulcers are deep and scirrhous.4% of 
gastric ulcer is due to malignancy. 
Common sites of peptic ulcer are 
- First part of duodenum 
- Along the lesser curvature of stomach 
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- Prepyloric and pyloric channel 
Gastric ulcer 
- Usually seen in late middle age. 
- incidence is same in both the sex and  
- increases with age. 
Duodenal ulcer 
- common in middle age 
- common in males in ratio of 3:1 
- in 10 – 20% both gastric and duodenal ulcers will be present 
Modified Johnson Classification of Peptic ulcer
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Type 1-ulcer along the body of stomach 
Type2-duodenal ulcer along type-1 
Type3-ulcer within 3 cm of pylorus 
Type4-ulcer in the upper part of stomach 
Type4-ulcer can occur anywhere in the stomach. 
Type 5-with NSAID usage 
Type2 and 3 are associated with excess acid secretion. 
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Causes 
-H pylori is the most common cause 
-NSAID,aspirin 
-smoking 
-spicy and irregular diet, coffee 
-endocrine causes like Zollinger Ellison syndrome, parathyroidism 
-emotional factors 
-genetic  
 
Pathogenesis 
-loss of mucosal defence 
-excessive acid secretion mainly in duodenal ulcer 
-decreased bicarbonate secretion 
-decreased prostaglandin secretion 
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H pylori hydrolyses urea to produce ammonia which in turn increases gastrin 
secretion. 
Symptoms usually include abdominal pain,bloating,nausea,loss of weight and 
melena. 
Diagnostic tests include barium study,endoscopy and endoscopy with biopsy. 
The various tests for H pylori include 
-urea breath test 
-culture of the biopsy specimen 
-rapid urease test 
-stool antigen test 
-histological examination 
 
Treatment 
-reassurance 
-medical treatment 
a.H2 blockers 
b.proton pump inhibitors 
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c.antacids 
d.prostaglandin analogue 
e.prokinetics 
HELICOBACTER PYLORI 
The discovery of H pylori and its relation with gastritis was discovered in 1982 by 
Warren and Marshall led to the various studies regarding the pathogenesis of 
gastro duodenal lesion. 
It is a gram negative bacteria which is spiral shaped and motile and it colonises in 
the submucosal layer over the epithelial cells. Though it can be seen throughout the 
stomach it is mainly concentrated in the antrum of thestomach, as parietal cells are 
less here. 
Faeco-oral or oro-oral route are the path of transmission. So H pylori are 
demonstrated in gastric juice and saliva by PCR method. 
It is more common in developing countries like India. Poor living condition is 
attributed to its high prevalence in developing countries. They are equally present 
in both males and females and rate is high among smokers. 
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PATHOGENESIS OF H. PYLORI INFECTION 
   Cag A gene is said to be present in most of the patients with gastric ulcer or 
carcinoma of stomach.H pylori contains Cag A gene but toxigenic in only 40% 
strains. It reaches the mucosa through its characteristic motility and adheres to the 
mucosa. The organism contains urease which produces a basic environment by 
converting urea to ammonia and it protects itself from the gastric acidity. 
As the organism is located to the mucosal lining the various immune cells cannot 
reach there, thus protecting the organism. But the vicious cytotoxic immune 
response leads to the damage to the gastric mucosa leading to ulcerative lesion. So 
it is the immune response to the organism which produces the ulcer and not 
directly the organism. Thus, though the organism is non invasive, it produces 
gastritis indirectly by inflammatory response. If the infection gets established it 
stimulates the G- cells to release gastrin leading to hypergastrinemia. 
Hypergastrenemia in turn lead to duodenal ulcer by stimulating parietal cells to 
produce acid. 
But the exact role of H pylori in pathogenesis of gastric ulcer is not known.it is 
thought  to be due to reduced gastric resistance to pepsin and acid
34
. 
The host immune response is similar to other bacterial infection- acute neutrophilic 
infiltrate followed by chronic cell infiltrate with Th1 response predominating. 
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In association with H pylori chronic gastritis is classified
35
 into 
Type A- atrophic with parietal cell antibodies
 
Type B-no parietal cell antibodies 
Type AB-both atrophic and patchy 
Chronic gastritis has the risk of development of adeno carcinoma.H pylori 
infection is more strongly associated with duodenal ulcer than gastric ulcer with 
prevalence almost 100%. 
Diagnosis of H pylori infection 
There are invasive and non invasive method 
Invasive 
-culture  
-histopathology of the biopsied specimen 
-rapid urease test 
Non invasive 
-serology 
-urea breath test 
- stool antigen test 
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-PCR 
-Urine antigen 
 
The choice of the appropriate test depends upon 
-sensitivity and specificity 
-cost 
-availability 
-patient willing to undergo endoscopy 
The main use of history taking and examination is to  
-to find if dyspepsia is due to NSAID induced or due to GERD 
-If the patient has alarm symptoms or not 
Patients with reflux symptoms should be treated as GERD.Patient with alarm 
symptoms should be investigated early, and endoscopy should be done. Though 
malignancy is rare,it is more common in patients with alarm symptoms than with 
simple dyspepsia. 
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MANAGEMENT OF  DYSPEPSIA 
Dyspepsia can be managed usually in five different methods
35
 
a.acid suppression 
b.H pylori non invasive test as mentioned above followed by H pylori eradication 
therapy for positive cases 
c.non invasive test followed by endoscopy for positive cases 
d.empirical H pylori treatment without non invasive or invasive tests 
e.early endoscopy 
With alarm symptoms 
Patients with alarm symptoms after age of 55 years should have early endoscopy 
done as there is clear cut increase in malignancy rate. The optimal age ischosen as 
55 years because below which the incidence is less than 10 per 100,000. 
Without alarm symptoms 
In treating patients with new onset dyspepsia without any alarm symptoms in 
majority of cases empirical acid suppression drugs are usually prescribed initially. 
However as mentioned above there are other options like testing for H pylori and 
starting eradication therapy in positive cases or doing endoscopy in positive cases 
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As the incidence of ulcer is low in new onset dyspeptic patients below 45 years 
American college of physicians based on various studies recommended acid 
suppression antisecretory therapy as the treatment of choice below 45 years of age 
without organic disease. They also suggested that if the symptoms do not decrease 
in 7- 10 days or if the symptoms have not completely resolved in 6-8 weeks, then 
endoscopy should be done. But this age threshold is still debatable. 
Collected data suggest that initial H pylori test followed by treatment is more cost 
effective than empirical acid suppression therapy. 
Various therapies of treatment include 
1.PPI therapy 
2.Acid suppression 
3.Prokinetic therapy 
4.H.pylori eradication therapy 
5.Psychological therapy 
                Among  these  therapies, only PPI therapy and H.Pylori eradication 
therapy are highly efficacious in treating functional dyspepsia
36
. In patients who 
are H.Pylori positive, H pylori eradication therapy is very cost effective as it has a 
long term effect when given once. In patients who don‘t respond to eradication 
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therapy and who are H pylori negative, PPI therapy for one month is 
recommended. 
                 Many studies have tried to establish association between H pylori and 
non ulcer dyspepsia so that the patients can be treated by eradication therapy.But 
no concrete evidence is available.In Germany ,a study done was by Bajorsky et al, 
he came to a conclusion that  H pylori infection per se causes dyspepsia
37
. In that 
study when all important causes of dyspepsia was excluded,85% HP-positive 
patients showed improvement after eradication therapy.But in this,in  many 
patients the symptoms decreased partially only,they did not recover fully which 
proves that inflammatory infiltrates partly persists in gastric mucosa.This proves 
that HP gastritis is an important etiological factor in causing dyspeptic symptoms. 
                    In 1997,the first national workshop on H pylori was held in Mumbai 
,which had these significant conclusions
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 H pylori infection in healthy and asymptomatic persons- prevalence 
rate in India varies from 31 to 84% 
 Factors like socioeconomic status,age,sanitation,housing and methods 
used in diagnosis mainly determines the prevalence rate 
 In India the age related prevalence study showed that infection occurs 
at an earlier age here compared to western countries 
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 No association was found between degree of gastric inflammation and 
non ulcer dyspeptic symptoms and the frequency of non ulcer dyspepsia 
varied from 60-85% 
 There is no big study contributing the association between histological 
picture of gastric mucosa and its symptom response 
 The preferred mode for diagnosis of H pylori infection is invasive 
techniques and among them rapid urease test is very popular. 
   The house urease test was found to be cheap and more sensitive when compared 
to Helicochek kit, the commercially available one.This was done by Anitha 
Kamath et al, using histology as gold standard she compared the sensitivity and 
specificity of both the tests.      
The prevalence of H pylori infection in gastroduodenal diseases was studied by 
Thayumanavan L et al a Madurai
38
during routine upper gastrointestinal 
endoscopies.He came to a conclusion that in southern parts of Tamil Nadu the 
organism has a wider prevalence rate and also for detecting the organism  rapid 
urease test is cheap,useful and simple and its prevalence is almost as high as non 
ulcer dyspeptics as those with duodenal ulcer.  
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Also serology is ideal for epidemiological studies.For confirming eradication in 
research setting, culture should be included in the protocol till urea breath test is 
available widely. 
The study by Warren Marshall concluded that more than 90% of patients with 
duodenal ulcer was infected with H pylori when it was compared with 40% of 
control group. In 43-79% of NUD patients H pylori infection was evaluated by 
four endoscopic surveys.These numbers were above the control group in 3 of these 
surveys conducted.Also no symptoms was seen in 50% of infected persons.Reflux 
like or ulcer like symptoms were seen in these infected persons. 
A statistically significant and convincing association was established by 
EUROGAST study group
40
 . It showed a positive association between H pylori and 
gastric cancer in different parts of the world.   
In patients with upper GI symptoms using the rapid urease test  a significant 
prevalence was seen in both  ulcer and non ulcer dyspepsia by PC Jain et al. 
Despite normal endoscopy ,significant mucosal lesions were seen in patients with 
infection by histopathological evidence. His study was done in Nigeria. Otherwise 
there are few studies on histopathological evidence and its relation with the 
organism. In India there are no studies. 
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 H.PYLORI ERADICATION THERAPY 
Whether the patients are suffering from initial presentation of the disease or its 
recurrence, if they have gastricor duodenal ulcer and if they are infected with H 
pylori, they should be treated with antimicrobials. Any drugs that is known to 
cause dyspepsia should be stopped  or substituted if possible. But it remains 
controversial in treating H pylori in non ulcer dyspepsia patients. A negative test 
for H pylori atleast 28 days after therapy is considered as H pylori eradication. 
 
FACTORS WHICH MODIFY TREATMENT 
 Urease based tests may fail to detect residual infection or recurrence if 
treated priorly with PPI or bismuth as they inhibit urease enzyme. 
 Biopsy based tests become inaccurate because H pylori tends to move to 
proximal part of stomach during suppression of acid seceretion. 
 The gold standard test to confirm eradication is C13 and C14 urea breath test 
as they sample the whole stomach.It takes atleast 6 months for antibody titre 
to fall significantly so serology is no useful to confirm eradication 
 In 50-80%, dual therapy with a 2 week combination of ranitidine or 
omeprazole or bismuth citrate and either clarithromycin or amoxicillin 
eradicated H pylori. Eradication rate may be 50-70% in triple therapy.PPI 
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based therapy for 1wk twice daily caused eradication in about 90% 
patients.7days treatment with omeprazole and amoxicillin and metronidazole 
or a PPI regimen is considered second line. 
 
TRIPLE REGIMENS WITH AMOXCILLIN AND METRONIDAZOLE 
 
 REGIMEN 1 REGIMEN 2 REGIMEN 3 
Drug Omeprazole+ 
Amoxicillin+ 
Metronidazole 
Ranitidine+ 
Amoxicillin+ 
Metronidazole 
Bismuth+teracycline/ 
Amoxcillin 
Metronidazole 
Dose 
(daily) 
40mg once+ 
500mg thrice+ 
400mg thrice 
300mg once+ 
750mg thrice 
500mg thrice 
120mg 4 times+ 
500mg 4 times+ 
200-400mg 4 times 
Duration 7 days 12 days 2 weeks 
Efficacy 95% 90% 60-90% 
Side effects Diarrhea,nausea with metronidazole 
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The above triple regimens are now been replaced by amoxicillin or 
clarithromycin along with a PPI which are shorter regimens. In eradication 
they are equally effective. 
 
 
 
LOW DOSE TRIPLE THERAPY 
LOW DOSE TRIPLE THERAPY 
 REGIMEN 1 REGIMEN 2 
Drugs PPI+Clarithromycin+ 
Metronidazole 
PPI+Amoxicillin+ 
Clarithromycin 
Dose(daily) Once/twice daily+ 
250mg twice+ 
400mg twice 
Twice+ 
1gm twice+ 
250-500mg twice 
Duration 7 days 
Efficacy 90% 90% 
Side effects Uncommon:diarrhea,nausea with 
metronidazole 
 
 QUADRAPLE THERAPY 
   PPI(once/twice daily)+ 
   Colloid bismuth sub citrate(120mg 4 times daily)+ 
   Tetracycline (500mg 4 times daily)+ 
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   Metronidazole(400-500mg 3-4 times daily) 
Duration of therapy: 7 days 
Efficacy : 85-95% 
Side effects:diarrhoea,nausea 
 
SEQUENTIAL THERAPY 
DAY 1-5 
PPIs twice a day 
Amoxicillin 1 gm twice a day 
DAY 6-10 
PPIs twice a day 
Clarithromycin 500 mg twice a day 
Tinidazole 500 mg twice a day. 
                       98% eradication rate is obtained by sequential therapy. It is 
suggested that sequential therapy should be made as the standard eradication 
therapy for H pylori as it gives a higher eradication rate than the conventional 
triple therapy. 
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SURGICAL TREATMENT 
a.Anti-reflux surgery like fundoplication 
b. Endoscopic therapy 
        Recently developed therapies likeradiofrequency energy and Plexiglas 
injection are less invasive than anti-reflux surgery like fundoplication. 
 
c.Peptic ulcer surgery 
 
 
1.Truncal vagotomy 
          Division of the main trunk of the vagus resulting in denervation of pylorus 
part of the stomach. In case of truncal vagotomy pylorus drainage procedure is 
needed. 
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2. Selective vagotomy  
      Only the nerve of Latarjet which arises below the celiac and hepatic branches is 
divided. This procedure also requires pylorus drainage procedures This procedure 
is usually not done. 
3.Highly Selective Vagotomy 
      It involves only the division of branches innervating the antrum and pylorus of 
stomach. Drainage procedure is not needed as the pyloric part is not denervated. 
In some cases vagotomy with anterectomy is done like  
      Bilroth I  
      Roux-en-Y Gastrojejunostomy 
These procedures have the low recurrence rate. 
 
GASTRIC CANCER 
       It is the fifth leading cause of cancer in the world and third leading among 
death due to cancer
41
. It is common in East Asia and East European countries. In 
India it is more common in southern india. Incidence of gastric cancer in India in 
2001 was 35,675 (23,785 males and 11890 females)
42
. 
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Etiology 
Exact etiology is not known. Various risk factors are 
a.H pylori –though 65-80% gastric cancer patients are H pylori positive only 2% of 
infected persons develop malignancy.it is due to long standing inflammation or 
virulence factor like Cag A
43 
b. Smoking is an important risk factor. 
c.Dietary factors-smoked food, processed meat, pickled vegetables, salt rich food 
d. Other risk factors include iodine deficiency, genetics, immune compromised 
state,chronic atrophic gastritis,intestinal metaplasia, genetic. 
 
Symptoms 
-often asymptomatic 
-non specific symptoms like abdominal pain ,discomfort, bloating, nausea, 
vomiting, weight loss, haemetemesis, melena, loss of weight and appetite, 
weakness, fatigue 
Investigation include endoscopy followed by endoscopic biopsy of any suspected 
lesion in stomach, CT abdomen and pelvis. 
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Treatment 
Surgery is the treatment of choice for gastric cancer.it includes 
a.endoscopic mucosal or sub mucosal resection 
b.wedge resection 
c.partial or subtotal gastrectomy 
d.laproscopic gastrectomy 
FUNCTIONAL DYSPEPSIA 
When the chronic or recurrent gastrointestinal symptoms cannot be explained by 
structural or biochemical abnormalities it is called as functional dyspepsia. It can 
be due to dysfunction right from oropharynx to large intestine including the biliary 
tract. 
   It is a heterogenous syndrome. They can be subdivided which may suggest the 
possible underlying pathology. 
It includes 
Ulcer like dyspepsia 
- they usually have the typical symptoms of peptic ulcer 
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Dysmotility-dyspepsia 
- symptoms that suggest gastric stasis or intestinal dysmotility like nausea, 
fullness and regurgitation 
Reflux-like dyspepsia 
- epigastric pain with heart burn or regurgitation 
  H pylori has not been associated significantly with non ulcer dyspepsia in 
epidemiological studies. Various other factors like increased acid secretion, stress, 
dietary factors and psychological factors have not been clearly or convincingly 
associated with non ulcer dyspepsia. 
 
Pathophysiology 
a. Delayed gastric emptying 
     It occurs when the antral peristalsis gets impaired or when the duodenal 
resistance is increased. The measurement of gastric emptying in relation to a meal 
is used to assess the efficacy of gastric neuromuscular work. It usually ranges 
between 20-50%. Few patients have delayed gastric emptying for solids. Studies 
have shown that it is more common in females than males. But many studies have 
shown that there is no relation between delayed gastric emptying and dyspepsia. 
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Postprandial intake of water decreases the antral gastric motility and increase in 
cholecystokinin. This is due to flow of fatty chyme into the duodenum which in 
turn inhibits antral peristalsis known as ‗duodenal break‘. Similarly low viscosity 
meal delays gastric emptying more compared to high viscosity meal because of the 
rapid initial inflow into the duodenum which inhibits the antral peristalsis. So these 
may be more important factors in causing symptoms especially in postprandial 
distress syndrome. 
b.Hypersensitivity to gastric distension 
      Some patients with functional dyspepsia are hypersensitive to gastric 
distension. It is related to 
-mechanoreceptors or chemoreceptor sensitization 
-increased exitability of spinal cord neurons 
-dysfunction of spinal inhibitory symptoms 
-altered CNS modulation and processing of visceral stimuli 
c. Altered duodenal sensitivity to lipids 
        Nutrient lipids increases the perception of gastric distension as it releases 
cholecystokinin. Patient with functional dyspepsia had increased duodenal acid 
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exposure compared to normal people on duodenal pH monitoring. This is due to 
impared acid clearance. 
d. Impared gastric accommodation 
Proximal stomach functions as a reservoir of food following a meal while the distal 
stomach is responsible for grinding the particles small enough for emptying into 
the pylorus. If relaxation of the proximal stomach through vagal reflux is impaired 
then large volume of food cannot be accommodated in the proximal stomach. 
Various studies have shown that impaired gastric accommodation is seen in around 
40% of functional dyspeptic patients. 
Various other mechanism leading to dyspepsia include 
- unsuppressed contraction of proximal stomach in the postprandial phase 
- myoelectric abnormalities 
OTHER CAUSES 
-metabolic disturbance 
-biliary disease 
-irritable bowel syndrome 
-pancreatic disease 
-psychiatric disease 
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ENDOSCOPY 
HISTORY AND DEVELOPMENT 
Earlier rigid endoscope with smaller lamps were used. But it had the disadvantage 
of overheating and also due to its rigidity it cannot be passed through the 
curvatures of intestine. It was initially designed by Polish surgeon Johann Von 
Mikulicz Radecki of 19
th
 century. 
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Flexible endoscopy(semi rigid) was first introduced by R.Schindler in 1936in 
association with Georg Wolf a German physician. Flexible fibroscope was first 
discovered by Baird in 1928.
 
 
The first clinically usable flexible endoscope was discovered by C.Wilbur Peters in 
association with Lawrence Curtis, a physics student. The problem of fibre cross 
talk which made the interpretation impossible was rectified by the discovery of 
glass coating of fibres for insulation. This lead to the development of fiberscope.   
The controllable tip gastroscope was discovered in 1962 by Hisschowitz . The first 
commercial endoscope was made by Inc  Norwalk CT in 1961. Various studies 
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were done to look for the usefulness against the complication of endoscope and 
today it had developed to an extent that endoscopic surgeries are being done.  
INSTRUMENTATION 
Various flexible endoscopes are available based on their dimensions, direct 
viewing or video. The primary endoscope is a zero degree forward viewing. In case 
of duodenoscope it is 90 degree. Endoscope have a control head and an eye piece. 
The shaft has deflection ranging from 90-240 degrees in vertical position and 100 
degrees in horizontal direction.The insertion tube has diameter ranging from 5.5 
mm to 11 mm. 
The deflection tip is controlled by 2 knobs located on the control head. The larger 
knob controls up and down deflection and a smaller knob controls the horizontal 
deflection. In addition to the knobs there are two buttons.the top button when 
pressed produces suction and the lower button produces air insuffulation. The 
lower button when pressed releases water for cleaning the tip.In case of video 
endoscope there are buttons which are used to take images. 
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The shaft in the flexible endoscope is 110-120 cm in length. The length of the 
working channel varies between 2 mm to 3.7 mm. In case of duodenoscope it 
varies between 3.2 to 4.2 mm. 
Biopsy forceps, brush to take cytology specimen and other instruments can be 
passed through accessory channel. At present a double lumenendoscope is also 
available for usage. 
69 
 
The light source usually 300w xenon or halogen tungsten lamp is connected to 
endoscope. Also the water and air pumps are attached to the endoscope for suction 
and insufflation. Video monitor if needed is connected to the endoscope. 
Good positioning and manipulation of endoscope is needed for efficient 
examination. Usually left hand is used to hold the control head, thumb holds the 
knob and middle and index finger hold the air insufflation and the suction buttons. 
The right hand adjusts the flexible shaft during examination. 
Endoscopy is the investigation of choice for patients with upper gastrointestinal 
problems. So clinician specialised  in uppergastrointestinal tract should be well 
versed in endoscopy. 
 
PATIENT PREPARATION 
First the procedure is explained to the patient in an understandable way and their 
consent is obtained. Previous treatment history is reviewed. The need for any 
medication like antibiotics are assessed. Patient should be advised overnight 
fasting. As most of the cases are out patients an attender should accompany them. 
In case  of relaxed patients, sedation may not be required but anxious patients can 
be sedated. A lignocaine spray for topical application can be tried before sedation. 
Sedation is usually done by diazepam or midazolam. 
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TECHNIQUE 
INTRODUCTION OF ENDOSCOPE 
    Patient is positioned in left lateral decubitus position after the required topical 
anaesthesia or sedation is given. A mouth piece is placed between the teeth. 
Endoscopy is advanced along the midline and structures in the oral cavity are 
visualised. Once the endoscope reaches the cricopharyngeus, patient is asked to 
swallow and gentle pressure is given so that endoscope enter the oesophagus. 
Examination of oesophagus 
For good vision optimal insufflation is needed and the endoscope tip should be in 
the centre of the lumen. If the vision is obscured scope should be withdrawn. 
As the endoscope passes through the lumen of the oesophagus, external 
compression at the four points asmentioned above will be noted. Oesophago 
gastric junction is usually noted at 38-40 cm from incisors and also there will be 
colour difference of the mucosa known as Z lines. To identify the position of 
oesophageal hiatus, patient is asked to inhale deeply so that diaphragmatic hiatus 
creates an imprint on the wall of oesophagus and stomach. 
 
 
71 
 
Passage into the stomach 
Before entering the stomach the lower oesophageal junction should be looked for -
whether it is normal, lax or constricted. Since the lumen of stomach is large the 
endoscope enters without any resistence. Patient may observe discomfort as the 
stomach gets distended with air. Greater curvature and the posterior wall is 
visualised once the tip is slightly turned downwards to the left. All the liquids in 
the stomach is suctioned for clear view of the stomach and also to prevent 
aspiration. If the endoscope is rotated the entire body of the stomach can be 
visualised. The proximal part of the curvature is visualised using J manoeuvre.J 
manoeuvre is done by rotating the scope by 180 degree upward when the stomach 
is distended. 
To view the antrum, tip of endoscope is angulated and the pyloric ring is observed 
directly. The endoscope is passed through the pylorus under direct vision. Once 
passed through the pylorus duodenal first part can be visualised till the superior 
duodenal angle. 
After viewing the duodenum endoscope is pulled out with stomach in the distended 
position to assess the proximal part of stomach along lesser curvature. When the 
endoscope is pulled back through the oesophagus the tip should be straightened. 
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Once the procedure is over, patient is observed and should avoid taking food or 
liquids for next 30 min. 
ENDOSCOPIC BIOPSY 
It is usually done once if there is any suspected lesion in the esophagus, stomach or 
duodenum. This include strictures, ulcers, mass lesions, polyps etc. Usually 
multiple specimens are taken to increase the sensitivity. If malignancy is suspected 
six biopsy specimen are usually taken. This will have sensitivity of more than 90-
95%. If any bleeding varices is suspected biopsy should not be taken as this may 
lead to bleeding. 
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Biopsy forceps are available in various dimensions. Biopsy instrument is 
introduced into the working channel, the jaws of the instrument opened and 
pressed on the mucosa and then closed and pulled back. If the forceps contain a 
spike, multiple biopsies can be taken without removing the forceps from the 
working channel for each biopsy specimen. 
Biopsy for stomach ulcer are usually taken at the base, that is the transition 
between the normal and abnormal mucosa in all four quadrants to improve the 
diagnostic accuracy. In case of mass in submucosal layer it is quite difficult to 
reach. Several biopsies need to be taken but there is always the risk of iatrogenic 
perforation. 
Polyps should be biopsied to rule out malignancy. For this purpose hot or cold 
forceps can be used for small polyp less than 5 mm and snare is used for large 
polyps or pedunculated polyp. Specimen should be obtained in case of oesophageal 
stricture. 
Japanese investigators have developed a suction apparatus which grasps the lesion 
and then the snare is placed at the base and lesion can be removed easily. If 
bleeding occurs coagulation technique is used. 
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Advantages of fibroscope
44
 
a. there are no blind spots, i.e., there is no part which cannot be visualised. 
b. fibroscope has made the procedure more simplified 
c.direct vision for biopsy has revolutionised the biopsy procedure 
d.recording ability has been improved. 
e.supplemental techniques are available like washing and application of pigment 
solution. 
Over all, the diagnostic accuracy has improved with advent of fibroscope. 
 
METHODOLOGY 
This is a prospective clinical study done at Kilpauk Medical College,Chennai, to 
find out the role of endoscopy in dyspeptic patients. The study duration was ten 
months from October 2013 to July 2014. Patients were selected using convenient 
sampling. 
Patients were included after getting their informed written consent for the 
procedure. Thorough clinical history was obtained through the proforma including 
the presence of alarm symptoms. Basic investigations were done. Ultra sonogram 
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of the abdomen done to look for gall stone or any mass lesion.  Then the patients 
were subjected to endoscopy and findings were noted. 
All the instruments were washed with distilled water to prevent error due to pH 
change. 
Inclusion Criteria 
a.patient age should be above 12 years 
b.patient for whom endoscopy was not previously done. 
Exclusion criteria 
a.patients below 12 years 
b.already known case of liver disease, pancreatitis,gall stone 
c.patient with unstable cardiac status 
d.pregnant women 
e.patient for whom endoscopy has already been done 
f.intake of NSAID, antibiotics or proton pump inhibitors within 15 days 
g.gastro intestinal bleeding 
h.severe systemic illness 
i.patient not willing for the procedure 
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PROCEDURE 
All the patients were on out patient basis. Cardiology fitness was obtained for all 
the patients above 40 years before the procedure
47
. Patient were on fasting for 12 
hours before the procedure. 
For most of the patients endoscopy was done under topical anaesthesia itself. Only 
few patients required sedation. Lignocaine spray was applied 10 minutes before the 
procedure. Diazepam 5-10 mg i.v was given for sedation. Patient was put in left 
decubitus position. 
The upper oesophago gastroduodenoscopy was done using Fujinon fibreoptic 
endoscopy. 
Under direct vision endoscope was introduced with the tip in the centre of the 
lumen. Under optimal insufflation oesophagus is looked for inflammation, ulcer, 
growth and stricture. As the endoscope passes through the lumen of the 
oesophagus external compression at the four points as mentioned above will be 
noted. 
Oesophago gastric junction is usually noted at 38-40 cm from incisor and also 
there will be colour difference of the mucosa known as Z lines. To identify the 
position of oesophageal hiatus patient is asked to inhale deeply so that 
diaphragmatic hiatus creates an imprint on the wall of oesophagus and stomach. 
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 Before entering the stomach the lower oesophageal junction should be looked for 
whether it is normal, lax or constricted. Since the lumen of stomach is large the 
endoscope enters without any resistence. Patient may observe discomfort as the 
stomach gets distended with air. Greater curvature and the posterior wall is 
visualised once the once the tip is slightly turned downwards to the left. All the 
liquids in the stomach is suctioned for clear view of the stomach and also to 
prevent aspiration. If the endoscope is rotated the entire body of the stomach can 
be visualised. The proximal part of the curvature is visualised using J manoeuvre.J 
manoeuvre is done by rotating the scope by 180 degree upward when the stomach 
is distended. 
To view the antrum tip of endoscope is angulated and the pyloric ring is observed 
directly. The endoscope is passed through the pylorus under direct vision. 
Endoscope can be advanced upto the second part of duodenum. 
Endoscopic biopsies were taken randomly in case of normal study. In case of 
ulcers, six specimens were taken, four from the edge of the ulcer and two from the 
antrum of the stomach. 
Among the six, two specimens- one from lesion site and one from the antral site 
and were inoculated in urea broth.It contains 0.5 ml of 1% Urea in distilled water. 
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If H pylori is present the colour of the solution will change from yellow to pink 
due to phenol red which acst as the indicator. 
Other four specimens are sent in formalin for histopathological examination. 
Specimen are fixed with 10% formalin, then processed with paraffin and sections 
are cut. Two specimens are stained with haematoxylin-eosin stain and other two 
with Giemsa stain. 
The H pylori test was considered positive if rapid urease tested positive or when 
histopathological examination was positive. 
Data were collected and data analysis done. 
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RESULTS 
Totally 150 patients were taken for the studyby convenience sampling method. 
Among which 92 were males and 58 were females. The patients were in age group 
ranging from 13 years to 86 years and the mean age was 43 years. 
Dyspepsia 
SI 
NO 
Endoscopic findings Male Female Total Percentage 
1 Normal 15 9 24 16% 
2 Oesophagitis 5 4 9 6% 
3 Oesophageal polyp - 1 1 0.6% 
4 Hiatus hernia 4 4 8 5.3% 
5 GERD 14 12 26 17.3% 
6 Barett‘s oesophagus 1 - 1 0.6% 
7 Carcinoma oesophagus 2 - 2 1.3% 
8 Gastritis 29 13 42 28% 
9 Gastric ulcer 3 3 6 4% 
10 Carcinoma stomach 3 1 4 2.6% 
11 Oesophagitis 1 5 6 4% 
12 Duodenitis 4 4 8 5.3% 
13 Duodenal ulcer 7 2 9 6% 
14 Gastroduodenitis 3 - 3 2% 
15 oesophagogastroduodenitis 1 - 1 0.6% 
 TOTAL 92 58 150 100% 
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Incidence of dyspepsia in different age groups 
Age groups No of  cases 
13-20 12 
21-30 31 
31-40 40 
41-50 17 
51-60 25 
61-70 18 
71-80 7 
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Upper gastro oesophago duodenoscopy was done for all patients. 
Normal study was seen in 28 patients. This accounts for 18%. Gastritis was seen in 
41 (29%) cases. This is the most common abnormal finding.GERD was seen in 
26(18%) cases followed by duodenal ulcer and hiatus hernia in 8 cases (5.6%) 
each. Gastric ulcer and duodenitis in 7 cases(4.9%) each. 
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Carcinoma stomach was noted in 4 cases(2.8%) and duodenal ulcer was diagnosed 
in 2(1.4%) cases. Oesophageal polyp and Barrett‘s oesophagus in 1 case each. 
When the endoscopic findings were subdivided based on the age group significant 
findings were in seen in 21-40 years. GERD is seen mainly in age group of 31-40 
years. 
 The inflammatory lesions were more common between 21-40 years of age. 
Dyspepsia due to ulcer was common in age group of 41-70 years. 
 
 Frequency of various diseases on endoscopy in different age groups 
Age 
grou
ps 
Norm
al 
study 
inflammmati
on 
ulce
r 
GER
D 
Malignan
cy 
othe
rs 
tot
al 
percenta
ge 
13-20 5 3 - 4 - - 12 8% 
21-30 6 17 2 6 - - 31 20.6% 
31-40 6 19 - 7 - 8 40 26.6% 
41-50 1 8 2 3 1 2 17 11.3% 
51-60 2 13 7 2 1 - 25 16.6% 
61-70 1 8 4 2 3 - 18 12% 
71-80 3 1 - 2 1 - 7 4.6% 
total 24 69 15 26 6 10 150 100% 
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In this study both oesophageal and gastric malignancy were common above 50 
years of age. 
Among the 150 cases 20 cases had alarm symptoms.13 cases were above 50 years 
of age and 7 cases were below 50 years of age. Among the 6 malignant cases, 3 
cases that is 50% had alarm symptoms 
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 In case of dyspepsia, inflammatory lesion was the most common pathology. 
Around 68(47.1%), among which 42(48%) are males and females are 25(46%). 
35% (7cases)
65%  (13 cases)
0% 0%
Distribution  of  alarm  symptoms
< 50 years ( 86 cases)
>50 years (64 cases)
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GERD was seen in 34 (24%) patients.18 cases among males and 16 among females 
Dyspepsia due to ulcer was seen in 15 patients among which 10(10.4%) are males 
and 5(7.4%) are females. 
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Oesophageal and gastric malignancy were seen in 5(5.7%) cases, only in males.
 
 
Among the 122 cases with significant findings, 52(42%) cases had pathology in the 
stomach, 46 (38%)cases had pathology in the oesophagus and 15(12.5%) cases in 
the duodenum. 
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Prevalence of clinically significant endoscopic findings according to the site of 
lesions 
SI 
NO 
CSF’S Age<50 
yrs 
Age>50 
yrs 
Total Percentage 
1 Oesophagus 37 10 47 37.3% 
2 Stomach 30 22 52 41.2% 
3 Duodenum 7 10 17 13.4% 
4 ESO+STO 4 2 6 4.7% 
5 STO+DUO 3 - 3 2.3% 
6 ESO+STO+DUO - 1 1 0.7% 
 Total 81 45 126 100% 
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Epigastric pain was the most common dyspeptic complaint seen in 112(78%) 
cases. Nausea and vomiting were seen in 104(72%) cases followed by heart burn in 
85(60%) cases ,Indigestion in 65(45%) cases and loss of weight and appetite in 
48(33.1%) cases 
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Frequency of various symptoms of dyspepsia in males and females 
 
SI NO Clinical presentation male female total percentage 
1 Epigastric pain 71 41 112 74.6% 
2 Heart burn 55 30 85 56.6% 
3 Nausea/vomiting 66 38 104 69.3% 
4 Food intolerance 28 22 50 33.3% 
5 Indigestion 40 25 65 43.3% 
6 Loss of weight/appetite 28 20 48 32% 
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The common clinical finding in H pylori positive cases was loss of weight and 
appetite(63%) followed by nausea and vomiting(42%). Epigastric discomfort was 
seen only in 36.6% cases. 
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Prevalence of H.Pylori in various in various clinical presentations 
 
 
Clinical presentation No of 
cases 
H.Pylori 
positive 
percentage 
Epigastric 
pain/discomfort 
112 21 36.2% 
Heart burn 85 17 29.4% 
Nausea/vomiting 104 24 41.3% 
Food intolerance 50 21 37.1% 
Indigestion 65 22 37.9% 
Loss of weight/appetite 48 21 36.2% 
 
 
 
94 
 
 
 
H pylori prevalence is slightly more in male patients(39.1%) when compared to 
females(37.9%). 
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Prevalence of H.Pylori in males and females 
 
Gender Total H.Pylori positive Percentage 
Male 92 36 39.1% 
Female 58 22 37.9% 
total 150 58 38.6% 
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Among the 28 patients with normal endoscopic study, 5 patients were positive for 
H pylori on rapid urease test. 
Although only  39% of dyspeptic patientswere associated with H pylori, it was 
100% positive in patients with oesophagogastroduodenitis followed by 75% in 
case of duodenal ulcer. 
In gastric and oesophageal carcinoma, 50% of patients were positive in this study. 
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Prevalence of H.Pylori in dyspeptic patients 
SI NO Endoscopic findings Total no H.Pylori positive Percentage 
1 Normal study 28 5 12.5% 
2 Oesophagitis 9 4 44.4% 
3 Oesophageal polyp 1 1 100% 
4 Hiatus hernia 8 1 12.5% 
5 GERD 26 11 42.3% 
6 Barett‗s oesophagus 1 - - 
7 Carcinoma oesophagus 2 1 50% 
8 Gastritis 42 19 45.2% 
9 Gastric ulcer 6 5 83.3% 
10 Carcinoma stomach 4 2 50% 
11 Oesophagogastritis 6 3 50% 
12 Duodenitis 8 4 50% 
13 Duodenal ulcer 9 4 44.4% 
14 Gastroduodenitis 3 - - 
15 Oesophagogastroduodenitis 1 - - 
 Total 150 58 38.7% 
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H pylori was more in the 51-60 years age group and least common in the 13-20 
years age group. 
Prevalence of H.Pylori in various age groups 
 
 
 
 
 
 
 
 
 
 
 
 
SI NO Age groups Total no H.Pylori 
positive 
Percentage 
1 13-20 12 2 16.6% 
2 21-30 31 4 12.9% 
3 31-40 40 12 30% 
4 41-50 17 7 41.17% 
5 51-60 25 21 84% 
6 61-70 18 10 55.5% 
7 71-80 7 2 28.5% 
 total 150 58 38.6% 
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DISCUSSION 
A clinical prospective study on ‗Role of endoscopy in patients presenting with 
dyspepsia‘ at Kilpauk Medical College, Chennai to study the usefulness of 
endoscopy in patients presenting with dyspepsia. 
Dyspepsia is a broad spectrum of symptoms with many differential diagnosis. So 
many persons have dyspeptic symptoms and it is practically difficult to perform 
endoscopy in all patients with dyspepsia taking into account the cost and man 
power. 
Hence this thesis is to study the appropriate role of endoscopy in management of 
dyspepsia. 
    Observations made in the study was comparable to many other studies in the 
past. Previous studies has indicated that endoscopy is not needed for simple 
dyspepsia in younger age group as initial diagnostic tool. 
    The study was done in 150 cases after getting their written consent for the 
procedure and the study.The study period was 10 months from October 2013 to 
July 2014. All the patients included in the study were subjected to upper 
oesophago gastroduodenoscopy and their findings were analysed. 
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CLINICAL PRESENTATION 
Most of the patients had epigastric pain or discomfort as their main complaint. It 
was present in nearly 114(79%) patients. Epigastric pain was followed by nausea 
and vomiting presenting in 104(73%) patients. Heart burn was the presenting 
complaint in 85 patients and indigestion in 68 patients. 
In the study conducted by Thomson ABR et al epigastric pain was present in 
34.3% of the study population followed by heart burn in 24.5%. This was quite 
comparable to our study regarding presenting complaints. 
 
COMPARISON OF AGE DISTRIBUTION 
  Most of the patients in the study were in the age of 31-40 years. Mean age in the 
study population was 43 years. 
The mean age in previous similar studies is shown the table 
Thus the mean age when compared with other studies was almost similar. 
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Comparison of age distribution 
 
 
 
 
 
COMPARISON OF GENDER DISTRIBUTION 
      Nearly 62% of study population were male and 38% were female. The various 
presentations of dyspepsia were common in males than females expect oesophago 
gastritis which were more common in females. 
Other similar studies that various presentation were common in males than 
females. In study conducted by Khan N et al male to female ratio was 2.3:1 and in 
study conducted by Ziauddin ratio was 1.6 : 1. 
But in one of the Australian based studies, females with dyspepsia were more than 
males. 
 
 
SI NO Name of study Mean age in years 
1 Thomson A B R et al 45.6 
2 Ziauddin 42.2+/-15.7 
3 Choomsri P et al 41 
4 Present study 43 
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COMPARISON OF VARIOUS ENDOSCOPIC FINDINGS 
 
Nearly 122 patients among 150 patients in our study presented with significant 
endoscopic findings. Inflammatory lesion was the most common endoscopic  
Finding, among which gastritis was the most common, accounting for 28.9% 
,followed by GERD.  In 18.3% oesophagitis, hiatus hernia and duodenal ulcer 
accounted for 8% each. 
  The incidence of gastritis was more when compared to other studies like studies 
by Sarwar et al and Ziauddin et al. But the incidence of GERD was comparable 
with study conducted by Sarwar et al. 
 
 
 
SI 
NO 
Name of the 
study 
Gastritis Reflux esophagitis/ GERD 
1 Sarwar et al 13% 20% 
2 Ziauddin 18% 14% 
3 Present study 28.9% 18.3% 
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PREVALENCE OF HELICOBACTER PYLORI 
   The H pylori incidence was more common in 51-60 years age group and least 
common in 13-20 years. This shows that the incidence of H pylori increases with 
age. The incidence of H pylori in males and females were equal and showed no 
significant difference. 
On comparing the clinical presentation with H pylori, surprisingly loss of weight 
and appetite was present in nearly 63% of cases. The next common symptom was 
nausea and vomiting present in 41.3% followed by indigestion(38.5%) and 
epigastric discomfort(36.6%). 
The incidence of H pylori in our study was 38.7%.in study conducted by Thomson 
et al it was 30% and Choomsri P et al was 23% 
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Prevalence of H.Pylori in dyspeptic patients 
 
SI 
NO 
STUDIES H.Pylori positive in 
percentage 
1 Choomsri P et al 23% 
2 Thomson ABR et 
al 
30% 
3 Present study 38.7% 
 
 
 
 
The incidence was highwhen compared to other studies. As people under study 
were from lower economic status this could be the reason for high incidence of H 
pylori in our study. 
When H pylori prevalence was compared with various endoscopic findings, H 
pylori was seen in 53.6% (22/41) of patients with gastritis and 71% (6/8) with 
duodenal ulcer and 60% (3/5) with gastric ulcer
50.
 
106 
 
Prevalence of H.Pylori in various studies and their endoscopic findings 
 
SI 
NO 
Name of 
study 
gastritis GU DU CA 
stomach 
1 Mustapha SK 
et al 
89.1% 61.9% 100% 33.3% 
2 Marshall et al 54.2% 81.8% 100% - 
3 Wulfen et al 62.2% 72.2% 83.3% - 
4 Vaira et al 57.6% 83% 92% 87% 
5 Present study 53.6% 60% 71% 50% 
 
H ELICOBACTER PYLORI IN SMOKERS 
Among the 92 males, 53 were smokers and 43 of them, i.e 82% were positive for H 
pylori and among 39 non smokers ,23 , i.e 55% were positive for H pylori. 
HELICOBACTER PYLORI AND LYMPHOID FOLLICLES 
Lymphoid follicles are commonly present in H pylori positive cases. In previous 
studies it ranges between 27% to 100%. So it was concluded previously that 
lymphoid follicles is a strong predictor of H pylori infection. 
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ALARM SYMPTOMS  AND ENDOSCOPIC FINDINGS 
  Alarm symptoms were present in 20 patients and 17 among them had significant 
endoscopic findings. The most important correlation was that among the 4 patients 
with gastric carcinoma 3 of them had alarm symptoms. 
COMPARISON OF INCIDENCE OF GASTRIC CARCINOMA 
     Four patients among the 150 patients were found to have gastric malignancy. 
Among the four, three were male patients and were above 50 years of age. The 
incidence of gastric carcinoma in study conducted by Khan et al was 3%, 
Choomsri et al was 1% and Ziauddin et al was 4%.Thus present study was 
comparable to other studies. 
 
Comparison of incidence of gastric malignancies 
 
SI NO NAME OF STUDY Percentage of gastric malignancies 
1 Choomsri P et al 1% 
2 Khan N et al 3% 
3 Ziauddin 4% 
4 Present study 2.67% 
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SUMMARY 
The study on ‗The role of endoscopy in patients presenting with dyspepsia‘ is a 
prospective clinical study conducted on 150 patients with dyspeptic symptoms in 
Kilpauk Medical College, Chennai. 
   Patients included in the study were first interviewed for various dyspeptic 
symptoms including alarm symptoms. Then all the patients were subjected to 
endoscopy and based on the endoscopic findings patients were subjected to various 
tests - endoscopic biopsy, histopathological examination, rapid urease test. The 
results were analysed.  
Significant endoscopic findings were seen in 84.5% of the study group.Gastritis 
and GERD was present in majority of the cases. Patients with simple dyspepsia did 
not have serious lesions in majority of the cases during endoscopy. Mucosal 
inflammatory lesions were seen in patients positive for H pylori organism. Gastric 
or oesophageal malignancy was present mostly in patients above 50 years of age 
and 50% of them had alarm symptoms. Only 1 person among the 150 cases, below 
50 years of age was diagnosed to have gastric carcinoma   
Hence the study shows that endoscopy is not required in patients less than 50 years 
of age with no alarm symptoms.Testing for H pylori for all dyspeptic patientsand 
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starting on anti H pylori regimen was cost effective compared to the initial 
endoscopy for dyspeptic patients. 
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CONCLUSION 
     Based on the present study on ―The role of endoscopy in dyspepsia symptom 
complex‖ done in Kilpauk medical college, we conclude that- 
- Prevalence of dyspepsia was more in 31-40 years age group and more 
common in males than females. 
- Epigastric pain or discomfort is the most common presenting symptom in 
dyspeptic patients 
- Gastritis was the most common endoscopic finding 
- Among the study population H pylori prevalence was 39% 
- Incidence of malignancy among the study population was 4% 
- Among the 6 malignant positive cases 5 were above 50 years of age 
    -   Endoscopy should be recommended for patients presenting with dyspepsia           
with alarm symptoms as the correlation between alarm symptoms of dyspepsia and 
gastric lesions were significant 
    -  In patients without alarm symptoms below 50 years of age there was no 
significant endoscopic findings. So these patients should be treated initially rather 
than subject them to endoscopy. 
  -  H pylori prevalence was more in age group above 50 years than younger age 
group thus H pylori infection increases with age 
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  -  Smoking is an important risk factor for H pylori infection. 
  -  Presence of lymphoid follicles in histopathology significantly correlates with H 
pylori infection 
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MASTER CHART 
S 
NO 
NAME AGE GENDER OP NO CLINICAL   FEATURES SIGNS ENDOSCOPIC 
FINDINGS 
H.PYLORI HPe 
EP/D N/V HB FI IDG LW/A PA ET 
1 Rajesh 26 M 1214 Y Y Y Y Y N N N GDs - ACG 
2 Palanisamy 61 M 3243 Y Y N N N N N N NS - CGs 
3 Saritha 19 F 2267 Y Y Y N Y N N N NS - NSP 
4 Giridharan 52 M 3344 N N N Y Y Y Y Y Ds + HPG 
5 Thiagu 44 M 1678 Y Y Y N Y N N N BE - ACG 
6 Ramesh 21 M 2456 Y Y Y N Y N N N NS - NSP 
7 Leelavathy 58 F 1890 N N N N Y Y Y Y DU + CPDs 
8 Irudhayaraj 32 M 2432 Y Y Y Y N N N N HH - NSP 
9 Krishnan 34 M 2865 Y Y N N Y N N N Es - EE 
10 Lakshmi 72 F 2236 N N N N Y Y Y Y GERD + RE 
11 Shankar 28 M 3658 Y Y Y N Y N N N DU - CPGs 
12 Radha 31 F 2876 Y Y N N N Y Y Y Es - RE 
13 Mariappan 54 M 1457 N N Y Y Y Y Y N Es + EE 
14 Janaki 33 F 1008 N N N N N Y Y Y EGs + CGs 
15 Ravi 18 M 1577 Y Y Y N Y N N N Ds - CPDs 
16 Vandhana 31 F 2190 N N Y N Y Y Y N Gs + HPG 
17 Venkatesh 34 M 3454 Y Y N N Y N N N GDs - CGs 
18 Ramesh 28 M 2545 Y Y Y N N N N N DU - CPDs 
19 Kamatchi 59 F 1967 N N N N Y Y Y Y GU + ACG 
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20 Bhavani 69 F 2756 N N Y Y N Y Y N EGs + HPG 
21 Vijay 17 M 1354 Y Y Y N Y N N N NS - NSP 
22 Latha 33 F 1788 Y Y N N N N N N Gs - ACG 
23 Kowsar 60 M 2436 N N N N Y Y Y Y Es + RE 
24 Daniel 28 M 3867 Y Y Y Y Y N N N GERD - RE 
25 Vijaya 35 F 1089 Y Y Y N Y Y Y N Gs - CGs 
26 Prakasham 32 M 1577 Y Y Y N N N N N Gs - ACG 
27 Shobana 19 F 3787 Y Y N Y Y N N N GERD - RE 
28 Dhanapal 51 M 3554 Y Y N N N N N N Gs - ACG 
29 Asokan 50 M 1879 N N N N Y Y Y Y DU + CPDs 
30 Kannan 25 M 3578 Y Y Y N N N N N GERD - RE 
31 Varadharaj 63 M 2454 Y Y N N N N N N GERD - RE 
32 Ganeshan 42 M 1788 Y Y Y Y Y N N N GU - ACG 
33 Sudhandira 32 F 3566 N N Y Y N Y Y Y HH + HPG 
34 Geetha 34 F 1214 Y Y N N N N N N Gs - ACG 
35 Priyanka 27 F 1345 Y Y Y Y N N N N Gs - CGs 
36 Anandan 30 M 1675 N N N N N Y Y Y GERD + RE 
37 Sugumari 33 F 2547 N N Y Y Y Y Y N Gs + HPG 
38 Kanagu 68 M 2798 Y Y N N Y Y Y N DU - CPD 
39 Subashini 25 F 1808 Y Y N N N Y Y Y Gs - CGs 
40 Shanthi 41 F 2586 Y Y Y Y N N N N Gs - ACG 
41 Saraswathi 49 F 1898 Y Y Y N N N N N Gs - ACG 
42 Neelakandan 53 M 3564 N N N N Y Y Y Y Gs + HPG 
43 Gopalan 78 M 1303 Y Y Y Y N N N N EGDs - EE 
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44 Karthik 16 M 2342 Y Y N N Y N N N NS - NSP 
45 Ramani 35 F 1896 Y Y Y N N N N N Gs - ACG 
46 Hajeera 29 F 1635 Y Y Y Y N N N N GERD - RE 
47 Kaliammal 67 F 1457 N N N N N Y Y Y Es + EE 
48 Ramkumar 46 M 2277 N N Y Y Y Y Y N GERD + RE 
49 Rakesh 15 M 2785 Y Y N N Y N N N EGs - CGs 
50 Suganya 24 F 3688 Y Y Y N N N N N GERD + NSP 
51 Krishnaveni 62 F 1894 Y Y N N N N N N DU - CPD 
52 Moorthy 55 M 3746 Y Y Y Y Y N N N GU + ACG 
53 Subathra 43 F 2786 Y Y N N Y N N N GERD - RE 
54 Ashok 29 M 2576 N N N N N N N N NS - CGs 
55 Manimoli 21 F 3454 Y Y N N N N N N GERD - NSP 
56 Manikandan 58 M 2344 Y Y Y Y N N N N Gs + HPG 
57 Meenakshi 68 F 2143 Y Y N N Y N Y N CaS - Sig r c 
58 Kishore 20 M 1565 N N N N N N N N NS - NSP 
59 Rani 64 F 2435 N N Y Y Y Y Y Y GU + ACG 
60 Sundaram 56 M 3534 Y Y Y Y N N N N Gs - ACG 
61 Malarvizhi 45 F 3241 N N Y Y N Y Y N EP + Hyp P 
62 Dinesh 25 M 2236 Y Y N N Y N N N Gs - CGs 
63 Manishkumar 36 M 1756 Y Y N N N N N N HH - NSP 
64 Natarajan 40 M 1543 N N N N Y Y Y Y Gs + HPG 
65 Divya 24 F 1673 Y Y Y N Y N N N Gs - ACG 
66 Ravikumar 52 M 3435 N N Y N N Y Y N GU + HPG 
67 George 77 M 2565 Y Y N N Y N N N GERD + RE 
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68 Hariharan 42 M 2563 Y Y Y N N N N N NS - CGs 
69 Govindan 44 M 3285 Y Y N N N N N N Es + EE 
70 Yasaar 30 M 1134 N N Y N N Y Y Y Gs - ACG 
71 Akila 16 F 1644 Y Y N N Y Y Y N NS - NSP 
72 Jayanthi 31 F 2853 Y Y Y Y N N N N NS - CGs 
73 Sekar 62 M 1674 N N Y N N Y Y Y CaE + Sq c c 
74 Devanderan 33 M 2753 Y Y N Y Y N N N NS - CGs 
75 Karthikeyan 24 M 1134 Y Y Y N N N N N Gs + HPG 
76 Anbalagi 47 F 1672 Y Y Y Y N N N N Gs - ACG 
77 Babu 60 M 1965 N N N N Y Y Y Y NS + CGs 
78 Nazeer 25 M 2787 Y Y Y Y N N N N NS - NSP 
79 Saravanan 65 M 2674 Y Y N N Y N Y N CaS - Ade c 
80 Nandhini 32 F 2875 Y Y Y N N N N N NS + CGs 
81 Jayashree 29 F 2974 Y Y Y Y Y N N N Gs - ACG 
82 Thangavel 59 M 1674 Y Y N N N N N N Gs + HPG 
83 Guna 35 M 3236 Y Y Y N N N N N NS - NSP 
84 Seetha 72 F 2564 Y Y Y Y Y N N N NS - CGs 
85 Venkatesh 27 M 3854 N N N N N Y Y N Gs + HPG 
86 Sudhakar 43 M 2632 Y Y Y Y Y N N N Gs - ACG 
87 Subbaih 63 M 2743 N N Y N Y Y Y N Gs + HPG 
88 Gnanasekar 37 M 1965 Y Y Y Y N N N N NS - CGs 
89 Premkumar 18 M 2113 N N N N N Y Y Y GERD + RE 
90 Vaniammal 60 F 1920 Y Y Y N Y N N N Ds + HPG 
91 Valli 70 F 1056 Y Y Y Y Y N N N GERD - NSP 
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92 Vijayakumar 34 M 3452 Y Y N N N N N N NS - CGs 
93 Manokar 56 M 2433 N N Y Y N Y Y N GERD + RE 
94 Minnoli 24 M 3754 Y Y Y N N N N N Gs - ACG 
95 Arulmozhi 53 F 2455 Y Y Y Y Y N N N NS + CGs 
96 Vijaya 57 F 1674 Y Y N N N N N N EGs - CGs 
97 Pawlina 64 M 3545 N N Y Y N Y Y N Gs + ACG 
98 Sarasu 74 M 1212 Y Y N N N N N N NS - CGs 
99 Mythili 24 F 2132 Y Y Y Y N N N N EGs - NSP 
100 Victoria 41 F 1865 N N N N Y Y Y N EGs + HPG 
101 Bharathi 36 F 2667 Y Y Y Y Y N N N HH - CGs 
102 Maheshwari 38 F 2864 N N N N N Y Y Y Gs + HPG 
103 Bhoopathy 36 M 1865 Y Y Y Y Y N N N Gs - ACG 
104 Vignesh 23 M 2896 Y Y Y N N N N N Gs - CGs 
105 Thiruvaram 58 F 1087 N N N Y Y Y Y Y GERD + RE 
106 Jayagar 22 M 1554 Y Y Y N N N N N Gs - ACG 
107 Sanamal 56 F 2976 N N Y Y N Y Y Y Gs + HPG 
108 Vishnu 22 M 1564 Y Y N N Y Y Y N Gs - CGs 
109 Prabakar 45 M 2075 Y Y Y Y Y N N Y CaE + Ade c 
110 Dilipan 37 M 2176 Y N Y Y Y N N N Gs - ACG 
111 Rukumani 74 F 2396 Y Y N N N N N N NS - CGs 
112 Sulaiman 35 M 2455 Y Y Y Y N N N N Gs + HPG 
113 Balaji 18 M 1574 Y N N N Y N N N GERD - NSP 
114 Chelappa 61 M 3765 N Y Y Y N Y Y Y Ds + CPDs 
115 Kirubakaran 55 M 2753 Y Y N N N N N N DU + CPDs 
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116 Rajadurai 39 M 1325 Y Y Y Y N N N N HH - CGs 
117 Peter 24 M 1465 Y Y Y N Y N N N Es - EE 
118 Thirupathi 59 M 1921 Y Y N Y N N N N Gs + HPG 
119 Vaishnavi 23 F 2121 Y Y Y N Y N N N Es - RE 
120 Sureshkumar 46 M 1422 Y N N N Y N N N Ds - CPD 
121 Jayabalan 66 M 1889 Y Y N N N N N N Gs + HPG 
122 Sakthivel 20 M 1092 Y Y Y Y Y Y Y Y GDs - CGs 
123 Dhanalakshmi 39 F 1312 Y N Y N N N N N HH - NSP 
124 Esther 40 F 1674 Y Y N N Y N N N GERD - RE 
125 Velaiyudam 57 M 1442 Y Y Y N N N N Y CaS + Ade c 
126 Veerapan 30 M 1654 Y N Y N N N N N NS - CGs 
127 Narayanan 54 M 2245 Y Y Y N N N N N DU + CPDs 
128 Chandra 38 F 2432 Y N N N Y N N N HH - CGs 
129 Sounder 40 M 3215 Y Y Y N N N N N Gs + HPG 
130 Rajendran 57 M 2425 Y Y Y Y N Y Y N DU - CPDs 
131 Murugan 73 M 3786 Y N Y N N N Y Y CaS - Ade c 
132 Alexander 67 M 3190 Y Y Y Y N N N N Gs + HPG 
133 Aravindan 47 M 1365 Y N N N Y N N N GERD - RE 
134 Senduran 31 M 2674 Y Y Y N N N N N Gs + HPG 
135 Jaikumari 27 F 1321 Y Y Y Y N Y Y Y EGs - CGs 
136 Preethi 19 F 1644 Y N N N N N N N GERD + RE 
137 Balagopal 65 M 1899 Y Y Y N Y Y Y N Gs - CGs 
138 Shiva 35 M 3423 Y Y N N N Y Y N Gs - ACG 
139 Madhan 37 M 2323 Y N Y Y N N N Y GERD + RE 
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140 Vijayan 57 M 1563 Y Y Y N N N N N Gs + HPG 
141 Gowthaman 39 M 1765 Y Y Y Y Y N N N GERD - RE 
142 Sundari 48 F 5645 N Y N N N Y Y Y Ds + CPDs 
143 Malliga 24 F 2432 Y N N N N N N N NS - NSP 
144 Seetharaman 38 M 3864 Y Y N N N N N N HH - NSP 
145 Renuga 35 F 2342 Y Y Y Y N N N N GERD - RE 
146 David 38 M 2654 N Y N N N Y Y Y GERD + RE 
147 Hemalatha 26 F 1177 Y N Y N Y N N N NS - CGs 
148 Savithri 66 F 3433 N Y Y Y N Y Y Y GU + ACG 
149 Latha 32 F 1024 Y Y N N N N N N GERD - NSP 
150 kalaiyarasan 38 M 1207 Y Y N N Y N N N GERD - RE 
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KEY TO MASTER CHART 
S NO - Serial no                                     Es – Esophagitis                                               
NSP – No specific pathology                                         
OP NO - Out patient no                       Gs – Gastritis                                                    
EE – Esosinophilic esophagitis 
M – Male                                                Ds – Duodenitis                                                
RE – Reflux esophagitis 
F – Female                                             EGs – Esophagogastritis                                  
ACG – Active Chronic Gastritis         
Y – Yes                                                   GDs – Gastroduodenitis                                  
CGs – Chronic Gastritis 
N – No                                                        ESDs – Esophagogastroduodenitis              
HPG – H.Pylori Gastritis  
EP/D – Epigastric pain/discomfort             GU – Gastric ulcer                                           
CPDs – Chronic Peptic Duodenitis 
N/V – Nausea/Vomiting                                DU – Duodenal ulcer                                       
Hyp P – Hyperplastic polyp 
127 
 
HB – Heart burn                                           NS – Normal study                                          
Sq ca – Squamous cell carcinoma 
FI – Food intolerance                                    HH – Hiatus Hernia                                         
Ade c - Adenocarcinoma 
IDG – Indigestion                                           BE – Barett’s esophagus                                
Sig c c – Signet cell carcinoma 
LW/A – Loss of weight/Appetite                   EP – Esophageal polyp                                    
+      Positive                                                          -   Negative  
P – Pallor                                                              CaE – Carcinoma  
ET – Epigastric tenderness                            CaS – Carcinoma of stomach 
HPE – Histopathological examination  
GERD- Gastro oesophageal reflux disease                                             
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